Claim Missing Document
Check
Articles

Found 2 Documents
Search

Durasi Pengobatan Berpengaruh terhadap Jumlah Tiap Jenis Leukosit Penderita Tuberkulosis Paru Karol Octrisdey; Made Susilawati; Fitri Rachmillah Fadmi; Winioliski L. O. Rohi Bire
Holistic Nursing and Health Science Vol 9, No 1 (2026): June (Issue in Progress)
Publisher : Master of Nursing, Faculty of Medicine, Universitas Diponegoro, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.14710/hnhs.9.1.2026.%p

Abstract

Pulmonary tuberculosis (TB) remains one of the major public health challenges in Indonesia. The immune response to TB infection may be influenced by the treatment duration, which can be observed through changes in the composition of leukocyte types in patients undergoing therapy. However, limited studies identify the duration of TB treatment with leukocyte type count among pulmonary TB patients. This study aimed to analyze the influence of the treatment duration on leukocyte type count in pulmonary TB patients. This study implied an analytical observational design and involved 60 pulmonary TB patients selected from several health facilities. Data were collected through laboratory examinations to assess leukocyte profiles and medical record reviews to determine the treatment phase based on the duration of therapy. The data were analyzed univariately to describe the respondents’ characteristics by age and sex, and bivariate analysis used simple linear regression to assess the relationship between treatment phase and changes in leukocyte proportions. Findings showed significant effects of the treatment duration on the proportions of eosinophils (p = 0.032), lymphocytes (p = 0.005), and neutrophils (p = 0.018). Patients in a longer treatment phase exhibited an increase in lymphocyte counts, while eosinophils and neutrophils tended to decrease. These results indicate that the immune response to TB adjusts over time and that leukocyte profiles may serve as indicators of treatment effectiveness. This study provides valuable insights for healthcare professionals in understanding the immune dynamics of TB patients and optimizing therapeutic strategies to enhance treatment outcomes. AbstrakTuberkulosis paru masih menjadi tantangan besar kesehatan masyarakat di Indonesia. Respon imun terhadap infeksi tuberkulosis paru dapat mengalami perubahan sesuai dengan lama pengobatan, yang tercermin melalui perbedaan proporsi jenis leukosit pada pasien yang menjalani terapi. Penelitian yang mengindentifikasi pengaruh lama terapi tuberkulosis terhadap jumlah tiap jenis leukosit penderita tuberkulosis paru masih terbatas. Penelitian ini bertujuan untuk mengetahui pengaruh lama pengobatan terhadap tiap jenis leukosit (eosinofil, limfosit, monosit, dan neutrofil) pada pasien tuberkulosis paru. Desain penelitian ini adalah observasional analitik dengan jumlah sampel 60 pasien dari berbagai fasilitas layanan kesehatan. Data dikumpulkan melalui pemeriksaan darah dan penelaahan rekam medis untuk menentukan lama pengobatan. Analisis univariat digunakan untuk menggambarkan karakteristik responden, sedangkan uji regresi linear digunakan untuk mengevaluasi hubungan antara lama pengobatan dan komposisi jenis leukosit. Hasil menunjukkan adanya pengaruh yang signifikan antara lama pengobatan dengan jumlah eosinofil (p = 0,032), limfosit (p = 0,005), dan neutrofil (p = 0,018). Semakin lama pengobatan dijalani, terjadi peningkatan limfosit serta penurunan eosinofil dan neutrofil. Temuan ini menunjukkan adanya adaptasi imun selama terapi tuberkulosis paru dan dapat menjadi dasar dalam memantau efektivitas pengobatan.  
Pulmonary Tuberculosis Treatment Failure in Coastal Poasia: Determinants from a Case-Control Study Fitri Rachmillah Fadmi; Sri Mulyani; Karol Octrisdey; Wa Ode Sitti Justin; Yeni Riza
Health Dynamics Vol 2, No 11 (2025): November 2025
Publisher : Knowledge Dynamics

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33846/hd21104

Abstract

Background: Tuberculosis continues to be a major public health issue, particularly in coastal areas where access to healthcare services is often constrained and living conditions differ from inland settings. Treatment failure remains a persistent challenge for tuberculosis control programs at the primary healthcare level. This study aimed to identify factors associated with pulmonary tuberculosis treatment failure in a coastal primary healthcare setting. Methods: An analytical observational study with a case–control design was conducted, involving 48 participants, comprising 24 cases (treatment failure) and 24 controls (treatment success). Data were obtained from tuberculosis program records and through structured interviews. Bivariate analysis using the chi-square test was performed to identify potential determinants (p ≤ 0.25), followed by binary logistic regression to determine factors independently associated with treatment failure. Results: Treatment adherence was the only factor that remained significantly associated with treatment failure after adjustment (AOR = 14.81; p = 0.016). Other variables, including distance to health facilities, knowledge, history of comorbid disease, family support, anxiety, and the role of the treatment supervisor (Pengawas Minum Obat or PMO), did not show significant associations in the multivariable model, although some demonstrated a tendency toward increased risk. Conclusion: Adherence to treatment plays a decisive role in determining tuberculosis treatment outcomes. Strengthening adherence should therefore be prioritized to reduce treatment failure, particularly in coastal communities where structural and social conditions may affect patients’ ability to complete treatment.